Our mission is to create a new category of therapeutics that repair the damage caused by devastating diseases. Our core innovation is the discovery of a global master regulator, the Innate Repair Receptors (IRR), that produces cellular and tissue repair in various disease states. Our lead compound in clinical development, Cibinetide, is focused on addressing unmet needs in neuroscience and diabetes complications. We have developed an extensive peptide library of IRR activators, with in-vivo proof of concept efficacy for 10 unique compounds and an extensive catalogue of scientific literature in collaboration with leading academic researchers around the globe.
View Top Employees from Araim Pharmaceuticals, Inc.| Website | http://araimpharma.com |
| Revenue | $6 million |
| Funding | $8.1 million |
| Employees | 7 (2 on RocketReach) |
| Founded | 2006 |
| Address | 580 White Plains Rd Suite 210, Tarrytown, New York 10591, US |
| Phone | (914) 762-7586 |
| Fax | (914) 762-7292 |
| Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Therapeutic Devices, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Therapeutics |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Araim Pharmaceuticals, Inc. employee's phone or email?
Araim Pharmaceuticals, Inc. Questions
The Araim Pharmaceuticals, Inc. annual revenue was $6 million in 2024.
Michael Brines is the Chief Scientific Officer of Araim Pharmaceuticals, Inc..
2 people are employed at Araim Pharmaceuticals, Inc..
Araim Pharmaceuticals, Inc. is based in Tarrytown, New York.
The NAICS codes for Araim Pharmaceuticals, Inc. are [32541, 3254, 325, 32].
The SIC codes for Araim Pharmaceuticals, Inc. are [283, 28].
Top Araim Pharmaceuticals, Inc. Employees
-
2
-
33
Related Companies
